Participated · Series B · Nov 2021

Anyword provides an AI-based language optimization platform that combines large language models with performance data to help marketers design messages across channels. Its predictive model was trained on billions of data points from A/B tests across industries, channels, audiences and objectives. The model is nearly 80% accurate at predicting message performance and the company reports this translates to an average 30% lift for marketers. Since its March 2021 launch, Anyword has grown an average of 40% month over month and serves thousands of customers including Ted Baker, PetCareRx, and Condé Nast. Anyword has more than 1,000 customers and maintains headquarters in New York and Israel. The company plans to use new funding to fuel hiring, continue developing its proprietary AI technology, and onboard more marketing customers.

Participated · Seed · Sep 2021

Eleos builds AI agents and multimodal LLM-powered tools that streamline clinical documentation, surface care insights, and improve patient engagement for behavioral health providers. The company recently launched Eleos Compliance, a clinical documentation improvement (CDI) product that uses agentic AI to flag documentation errors and simplify appeals and accreditation work. Eleos uses the industry’s largest dataset of real-world treatment sessions and claims randomized controlled trial results showing >80% faster progress note submission, doubled client engagement, and 3–4x improved care outcomes versus treatment as usual. The company has more than 120 customer organizations across 30+ U.S. states and reports rapid revenue growth, tripling annual revenue over its first three years and doubling revenue in 2024. Eleos plans to use new funding to expand product offerings, grow its commercial team, hire senior leaders and engineering/data talent, and push into underserved segments—particularly substance use disorder and post-acute behavioral healthcare. Eleos Health develops AI that interprets, analyzes and documents behavioral health conversations using proprietary, behavioral health–specific large language models trained on treatment data and clinical expertise. The system reduces operational burden on providers by automating documentation and surfacing objective insights into evidence-based care and the therapeutic alliance. Leadership teams can scale supervision and training and gain visibility into staff activity, caseloads, performance and population health. The company plans new and enhanced AI solutions for group therapy, compliance automation, case management, concurrent documentation and value‑based care support. Eleos intends to expand its reach to more behavioral health providers and segments, deepen strategic partnerships with EHRs and industry associations, and hire more than 50 people by the end of 2024. It is led by CEO Alon Joffe and is based in Boston and Tel Aviv. Eleos Health provides CareOps Automation solutions that consolidate the behavioral care workflow by automating operational necessities, including documentation and compliance administration, and by delivering session intelligence. Its session intelligence tools generate clinical insights that enable clinicians, providers, and networks to track treatment and progress in a measurable way. The company is led by CEO Alon Joffe and is used by thousands of clinicians across more than 20 national care providers and health plans, including Gaudenzia Home, The Brookline Center for Mental Health, and Coleman Health Services. Eleos has captured more than 6.5 million minutes of treatment to date and is projecting 30 million minutes captured by the end of 2022. The company intends to use the funding to accelerate growth and expand its operations, team, and product. Eleos is based in Boston, MA. Eleos Health develops an AI-powered Speech-to-Insights system that analyzes behavioral health sessions to surface actionable insights for clinicians. Its VoiceAI technology runs securely in the background of sessions and analyzes hundreds of data parameters to accelerate clinical decision-making and personalize care. The company has deployed its solution with over a dozen provider organizations, including Solvista Health, Achieve, Yeshiva University and ReachLink. Eleos plans to use the recent funding to expand sales, marketing, and solution delivery teams needed to meet demand for enterprise software deployments across providers and payors. Founded in 2020 and based in Boston and Tel Aviv, the company has added Dr. David Shulkin to its board. Eleos closed a $6M seed round in 2021.

Participated · Series A · Apr 2018

Nutrino is a San Francisco- and Tel Aviv-based provider of nutrition-related data services and analytics technology. It offers an advanced platform and comprehensive food database that collates data from millions of food items globally and is used by companies across food & beverages, digital health, fitness and beyond. The company uses AI and machine learning to analyze feedback from wearables and other data points to understand individual responses to particular foods. Those contextual insights allow Nutrino to define an individual's FoodPrint, the digital signature of how food affects a person's body. Led by CEO Yael Glassman, Nutrino intends to use the Series A proceeds to expand its services across the digital health sector and sign additional partnerships. The company raised $8M in the Series A, bringing total funding to $10M. Nutrino is an iOS app that functions as a virtual nutritionist, delivering daily personalized meal plans informed by users' profiles, goals, habits and culinary tastes. Its recommendation algorithms, reportedly two years in the making, drive the personalization and meal-planning features. Users complete an in-app survey to build a profile (gender, age, height, weight, lifestyle, goals and preferences) and can sync weight data with Withings wireless scales for tracking. Each meal can be added to a grocery list that currently ties into UK supermarket chains Tesco and ASDA and connects with on-the-go outlets such as Pret, pod, eat, Costa Coffee and Café Nero. Nutrino plans to target communities with special nutritional requirements (e.g., people with diabetes, hypertension, athletes) with subscription-based tailored features, and seeks deeper grocery and take-out integrations. The startup has been funded to the tune of $400,000 from family and private investors. It was founded by Jonathan Lipnik, Yaron Hadad, Jose Luis Martin de Bustamente, Eduard Ros Bajona and Ido Cohn and is spread across the UK, Spain and Israel.

Led · Equity · Dec 2017

Ecoppia develops cloud-based, water-free, autonomous robotic systems that clean dust from solar panels daily using machine learning and IoT. Its platform is remotely managed and designed to maintain peak solar-site performance while minimizing O&M costs and human intervention. Ecoppia’s solutions are field-proven and deployed globally across utility-scale sites, and the company reports over 17GW of secured projects. Despite COVID-19 headwinds, Ecoppia secured more than 10GW of new projects in the last three quarters and has maintained a CAGR of over 200% in the past six years. Its customer base includes tier-1 energy companies such as ENGIE, EDF, Fortum, Actis and Brookfield. The company highlights proprietary algorithms and data-analysis capabilities as part of a roadmap toward fully data-driven, automation-based solar O&M and geographic expansion. Ecoppia develops cloud-based, waterless cleaning robots that remove dust from solar modules, using advanced data analysis and machine learning. The company sells automated, waterless cleaning systems designed to reduce soiling-related losses, particularly in water-scarce regions. Its pipeline was expected to top 2GW in 2018, and it says it has experience cleaning over 200 million solar panels worldwide. Ecoppia reports revenue growth of more than 1,600% over the past four years and describes itself as the fastest-growing cleantech company in Israel. The firm has deployed E4 cleaning robots at a 40MW plant on the Israel–Jordan border and agreed to provide systems to Solairedirect India for the Bhadla Solar Park. It plans to use new funding to meet sharp product demand, expand into new geographies, and launch new products.

Participated · Equity · Apr 2014

GreenSQL provides a software-based data security and compliance solution that prevents SQL injection attacks at the database layer while enforcing separation-of-duties for common databases. The product offers real-time protection from internal and external threats and has recorded over 150,000 downloads worldwide. The company intends to use the new funding for business expansion. GreenSQL is led by CEO Amir Sadeh. Founded in 2009 and based in Tel Aviv, Israel, the company focuses on database-layer security and compliance for the most common databases. GreenSQL delivers an all-in-one Unified Database Security product family that bundles database security, caching, auditing and masking in a single package. The company focuses on protecting databases from internal and external threats in real time while improving performance and demonstrating security compliance. GreenSQL's solutions target SMB/SME and enterprise markets and are designed to be easy to deploy and maintain via a unified management interface. The company says it is the most popular MySQL firewall solution, with over 100,000 downloads in 198 countries. GreenSQL announced it closed a $5.9 million Series B (up from an original $3.8 million) to support expansion to new markets and to adapt its product for virtual and cloud architectures. Management highlighted in the announcement includes CEO Amir Sadeh and security expert David Maman.